ADVFN Logo ADVFN

Hot Features

Registration Strip Icon for monitor 브라질 증권 거래소, NASDAQ, NYSE, AMEX, LSE 등 주요 거래소에서의 다양한 실시간 주식 시세를 모니터링합니다.
Chiasma Inc

Chiasma Inc (CHMA)

3.76
0.00
(0.00%)
종가: 06 1월 6:00AM
3.76
0.00
( 0.00% )
시간외 거래: -

개인 투자자를 위한 전문가급 도구.

주요 통계 및 세부정보

가격
3.76
매수가
3.76
매도가
3.80
거래량
-
0.00 일간 변동폭 0.00
0.00 52주 범위 0.00
전일 종가
3.76
개장가
-
최근 거래 시간
마지막 거래 시간
-
평균 볼륨(3m)
-
재정 규모
-
VWAP
-

CHMA 최신 뉴스

Pulmatrix appoints Director Anand Varadan

Pulmatrix appoints Director Anand Varadan PR Newswire LEXINGTON, Mass., July 27, 2021 LEXINGTON, Mass., July 27, 2021 /PRNewswire/ -- Pulmatrix, Inc. (NASDAQ: PULM), a clinical-stage...

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc.

ALERT: Rowley Law PLLC is Investigating Proposed Acquisition of Chiasma, Inc. PR Newswire NEW YORK, May 5, 2021 NEW YORK, May 5, 2021 /PRNewswire/ -- Rowley Law PLLC is investigating potential...

Chiasma Announces Pricing of a Public Offering of $70 Million of Common Stock and Pre-Funded Warrants

NEEDHAM, Mass., July 01, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its...

Chiasma Announces Proposed Public Offering of Common Stock and Pre-Funded Warrants

NEEDHAM, Mass., June 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial biopharmaceutical company focused on developing and commercializing oral therapies utilizing its...

Chiasma Announces FDA Approval of MYCAPSSA® (Octreotide) Capsules, the First and Only Oral Somatostatin Analog

MYCAPSSA is indicated for long-term maintenance treatment in acromegaly patients who have responded to and tolerated treatment with octreotide or lanreotide Conference call and webcast scheduled...

Chiasma Reports First Quarter 2020 Financial Results

NEEDHAM, Mass., May 07, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients who face challenges...

Chiasma To Report First Quarter Financial Results On May 7, 2020

NEEDHAM, Mass., April 30, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare and serious...

Chiasma Appoints Anand Varadan as Chief Commercial Officer and Reports Inducement Grant under NASDAQ Listing Rule 5635(c)(4)

NEEDHAM, Mass., April 22, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late stage biopharmaceutical company focused on improving the lives of patients who face challenges...

Chiasma Enters Into Revenue Interest Financing Agreement for up to $75 Million with Healthcare Royalty Partners

NEEDHAM, Mass., April 08, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical, late-stage biopharmaceutical company focused on improving the lives of patients with rare and serious...

Chiasma Reports Fourth Quarter and Full Year 2019 Financial Results

MYCAPSSA® PDUFA Date Set for June 26, 2020; U.S. Commercial Launch Planned in Q4’20 First Industry Sponsored U.S. Disease State Registry for Acromegaly Began Enrolling Patients NEEDHAM, Mass...

기간변동변동 %시가고가저가평균 일일 거래량VWAP
10000000CS
40000000CS
120000000CS
260000000CS
520000000CS
1560000000CS
2600000000CS

CHMA - Frequently Asked Questions (FAQ)

What is the current Chiasma share price?
The current share price of Chiasma is US$ 3.76
What is the 1 year trading range for Chiasma share price?
Chiasma has traded in the range of US$ 0.00 to US$ 0.00 during the past year

이동자

모두 보기
  • 가장 활성
  • % 상승자
  • % 패자
기호가격볼륨
HUBCWHub Cyber Security Ltd
US$ 0.0639
(59.75%)
300
MEGLMagic Empire Global Limited
US$ 0.866
(54.07%)
4.6M
PTLEPTL Ltd
US$ 11.30
(52.91%)
128.6k
FCUVFocus Universal Inc
US$ 1.2901
(34.53%)
11.23M
VEEETwin Vee PowerCats Company
US$ 0.6627
(34.42%)
7.17M
ACONAclarion Inc
US$ 0.20
(-32.98%)
12.79M
BCTXBriaCell Therapeutics Corporation
US$ 0.50
(-21.96%)
482.53k
NITON2OFF Inc
US$ 2.23
(-15.53%)
3.36M
RAINRain Enhancement Technologies Holdco Inc
US$ 5.05
(-13.53%)
20.82k
SYTASiyata Mobile Inc
US$ 6.08
(-10.46%)
164.95k
CNSPCNS Pharmaceuticals Inc
US$ 0.1529
(24.31%)
19.68M
QSIQuantum Si Inc
US$ 3.91
(-8.86%)
14.38M
ACONAclarion Inc
US$ 0.20
(-32.98%)
12.79M
FCUVFocus Universal Inc
US$ 1.2901
(34.53%)
11.23M
KITTNauticus Robotics Inc
US$ 4.72
(24.21%)
10.04M

CHMA Discussion

게시물 보기
ClayTrader ClayTrader 4 년 전
* * $CHMA Video Chart 05-05-2021 * *

Link to Video - click here to watch the technical chart video

👍️0
swampboots swampboots 4 년 전
Fool was right!
👍️0
SurgeGuy2.0 SurgeGuy2.0 4 년 전
I saw some fool MM pushing this on twitter! lolzzzzzz
👍️0
Xzibit Xzibit 4 년 전
CHMA - Insider Buying
👍️0
whytestocks whytestocks 4 년 전
Breaking News: $CHMA Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly

NEEDHAM, Mass., Aug. 31, 2020 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a commercial stage biopharmaceutical company utilizing its delivery platform technology to develop oral therapies to reduce the burden of chronic injections for people with rare diseases, today announced the com...

Read the whole news CHMA - Chiasma Announces U.S. Commercial Launch and Availability of MYCAPSSA®, the First and Only Oral Somatostatin Analog for Patients with Acromegaly
👍️0
Tempy Tempy 4 년 전
Great news after the bell...time to move on up, to the top!!!
👍️0
Tempy Tempy 4 년 전
Nice day here...let’s see if it continues.
👍️0
blue finch blue finch 5 년 전
Lots of potential here

👍️0
#NeverPennyLand #NeverPennyLand 5 년 전
Reversal imminent imo
👍️0
ClayTrader ClayTrader 5 년 전
* * $CHMA Video Chart 07-23-2019 * *

Link to Video - click here to watch the technical chart video

👍️0
JohnConnor67 JohnConnor67 5 년 전
Market Movers, July.23rd! Some light DD included for CHMA also!
Cheers!

https://interactiveswingtrading.com/2019/07/23/market-movers-july-23rd/
👍️0
stock1ace1 stock1ace1 5 년 전
Grabbed 8s
👍️0
whytestocks whytestocks 5 년 전
News: $CHMA Chiasma Announces Positive Phase 3 Top-Line Results from CHIASMA OPTIMAL Clinical Trial of Mycapssa® for the Maintenance Treatment of Adults with Acromegaly

SPA-agreed trial met primary and all secondary endpoints No new or unexpected safety signals in the Mycapssa treated patients 90% of the patients treated with Mycapssa who completed the 36-week study opted to continue into the Open Label Extension Company to host conference ca...

In case you are interested Chiasma Announces Positive Phase 3 Top-Line Results from CHIASMA OPTIMAL Clinical Trial of Mycapssa® for the Maintenance Treatment of Adults with Acromegaly
👍️0
europtiger europtiger 5 년 전
Got 8,10s

Stop 7,10
👍️0
europtiger europtiger 5 년 전
Buying 8,20,s
👍️0
behindthebid behindthebid 5 년 전
Co reported "positive" results from its Phase 3 results using Mycapssa for patients with acromegaly (disease where body produces too much hormone).

Daily Premarket watchlist with more information. Check it out at >>
https://www.behindthebid.com/posts/premarket-breakfast-for-tuesday-july-23rd
👍️0
McMahon McMahon 5 년 전
Chiasma management will host a conference call and webcast to discuss the CHIASMA OPTIMAL results in more detail today, July 23, 2019, at 8:30 am EDT.

The dial-in number in the U.S./Canada is 877-407-4018; for international participants, the number is 201-689-8471. For all callers, please refer to Conference ID 13692819.

To access the live webcast, please use the following link: http://public.viavid.com/index.php?id=135476
👍️0
saigai saigai 6 년 전
well made some money from 3-4 dollars and then got distracted chasing elsewhere ..I bought back 850 shares today at 6.45..easy money...should have just stayed put but im here for another ride..
👍️0
whytestocks whytestocks 6 년 전
News: $CHMA Chiasma to Participate in Three Investor Conferences in March

WALTHAM, Mass., March 04, 2019 (GLOBE NEWSWIRE) -- Chiasma, Inc. (NASDAQ: CHMA), a clinical-stage biopharmaceutical company focused on improving the lives of patients with rare and serious chronic diseases today announced that Mark Fitzpatrick, Chief Executive Officer and William Ludlam, MD...

In case you are interested https://marketwirenews.com/news-releases/chiasma-to-participate-in-three-investor-conferences-in-march-7800548.html
👍️0
saigai saigai 6 년 전
huge volume..a very strange day here
👍️0
saigai saigai 6 년 전
non stop institutional buying..straight line share building...a robert moses special....see you in the teens sooner than later
👍️0
saigai saigai 6 년 전
got 3k shares here and will ad a few more..this is going straight up with a little low volume consolidation here and there...
👍️0
saigai saigai 6 년 전
gonna be a good day ..no one home here
👍️0
gothambio gothambio 7 년 전
Still quiet after another 20%. This is good, no dumb traders involved yet just big funds passively buying. 10 bagger in making
👍️0
gothambio gothambio 7 년 전
surprised so quiet on here. I guess that's good for loading up
👍️0
tripil7z tripil7z 8 년 전
$CHMA long 1000 starter @ 1.35 beat down bio
👍️0
Jumboo Jumboo 8 년 전
Revenue beat !!!
👍️0
Jumboo Jumboo 8 년 전
Trading 44% lower than face value .. Even if the company goes BK .. You will make 44% money . Something doesn't add up here ...
👍️0
Betchips Betchips 8 년 전
Nice pop today, strong move pass the 50 day
👍️0
kany kany 9 년 전
CHMA is very undervalued, considered the Cash/Book above $5. Given a $4 PT for a month or two.
https://www.vetr.com/profile/kan
👍️0
kany kany 9 년 전
CHMA is very undervalued, considered the Cash/Book above $5. Given a $4 PT for a month or two.
https://www.vetr.com/profile/kan
👍️0
Jumboo Jumboo 9 년 전
Difficult chowdhury ji .. I am happy if it goes back to 5
👍️0
Shane Chowdhury Shane Chowdhury 9 년 전
When would we see $10 a share again?
👍️0
blue finch blue finch 9 년 전
Wait it out
Good entry here for a double
But you will have to wait for it
Oversold
👍️0
Jumboo Jumboo 9 년 전
Thoughts here
👍️0
blue finch blue finch 9 년 전
They have plenty of $$
They are meeting the FDA anytime now
After that i expect an update
The drug has marketability
However appears to be a long way off from bringing it forward
I don't know where the real price will be set
To be determined

Good luck

I appreciate your comments on the av&& board thank you
👍️0
XenaLives XenaLives 9 년 전
I have three stocks about to break major so I'm looking for candidates for new positions.

👍️0
blue finch blue finch 9 년 전
Poor management
Unaware more trials required
By FDA
Possible bounce soon


Stay with av@@
This is a long term hold or a trade in a few weeks IMO
👍️0
XenaLives XenaLives 9 년 전
Has anyone done any DD here????

Chart looks interesting, lawsuits are a nice contrarian indicator, what about the tech?

👍️0
gregque gregque 9 년 전
sold my position and bought ensco (esv) @ 9.49 check it out now
👍️0
Jumboo Jumboo 9 년 전
RSI 24... Way over sold .. Bounce is coming
👍️0
Jumboo Jumboo 9 년 전
Time for bounce ... Over sold ...
👍️0
blue finch blue finch 9 년 전
The accumulation phase is almost over
The washout - sellers are done
This should start to retrace soon

Good luck
👍️0
PStockPickz PStockPickz 9 년 전
i have no stake in this myself just looking for a flip but with no volume not going to bother
👍️0
ramalio ramalio 9 년 전
Glad having bought at 8.5 and sold at 10.5 ... rarely so lucky!
👍️0
blue finch blue finch 9 년 전
Check out the seeking alpha piece today
👍️0
PStockPickz PStockPickz 9 년 전
i will wait and see how this looks tomorrow, might grab bottom
👍️0
blue finch blue finch 9 년 전
6 million and counting

Wont see this tomorrow guaranteed
👍️0
blue finch blue finch 9 년 전
Ok here
👍️0
ClearlyStocks ClearlyStocks 9 년 전
Looks tempting, but wouldn't play it unless you are risking $20k or more to sell 5 cent pop. Doubt it flies back I
👍️0

최근 히스토리

Delayed Upgrade Clock